Literature DB >> 25234597

PRMT5 is essential for the eIF4E-mediated 5'-cap dependent translation.

Ji-Hong Lim1, Yoon-Mi Lee2, Gibok Lee1, Yong-Joon Choi3, Beong-Ou Lim1, Young Jun Kim1, Dong-Kug Choi4, Jong-Wan Park5.   

Abstract

It is becoming clear that PRMT5 plays essential roles in cell cycle progression, survival, and responses to external stresses. However, the precise mechanisms underlying such roles of PRMT5 have not been clearly understood. Previously, we have demonstrated that PRMT5 participates in cellular adaptation to hypoxia by ensuring 5'-cap dependent translation of HIF-1α. Given that c-Myc and cyclin D1 expressions are also tightly regulated in 5'-cap dependent manner, we here tested the possibility that PRMT5 promotes cell proliferation by increasing de novo syntheses of the oncoproteins. c-Myc and cyclin D1 were found to be noticeably downregulated by PRMT5 knock-down. A RNA immunoprecipitation analysis, which can identify RNA-protein interactions, showed that PRMT5 is required for the interaction among eIF4E and 5'-UTRs of HIF-1α, c-Myc and cyclin D1 mRNAs. In addition, PRMT5 knock-down inhibited cell proliferation by inducing cell cycle arrest at the G1 phase. More importantly, ectopic expression of eIF4E significantly rescued the cell cycle progression and cell proliferation even in PRMT5-deficeint condition. Based on these results, we propose that PRMT5 determines cell fate by regulating 5'-cap dependent translation of proteins essential for proliferation and survival.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5′-Cap dependent translation; Cyclin D1; Protein arginine methyltransferase 5; c-Myc; eIF4E

Mesh:

Substances:

Year:  2014        PMID: 25234597     DOI: 10.1016/j.bbrc.2014.09.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

2.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.

Authors:  Gregory V Kryukov; Frederick H Wilson; Jason R Ruth; Joshiawa Paulk; Aviad Tsherniak; Sara E Marlow; Francisca Vazquez; Barbara A Weir; Mark E Fitzgerald; Minoru Tanaka; Craig M Bielski; Justin M Scott; Courtney Dennis; Glenn S Cowley; Jesse S Boehm; David E Root; Todd R Golub; Clary B Clish; James E Bradner; William C Hahn; Levi A Garraway
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

3.  Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.

Authors:  Ruiying Yang; Shuhong Dong; Jinghui Zhang; Shihao Zhu; Guoliang Miao; Baolai Zhang
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

4.  PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.

Authors:  Guozhen Gao; Surbhi Dhar; Mark T Bedford
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

5.  Vanillin Suppresses Cell Motility by Inhibiting STAT3-Mediated HIF-1α mRNA Expression in Malignant Melanoma Cells.

Authors:  Eun-Ji Park; Yoon-Mi Lee; Taek-In Oh; Byeong Mo Kim; Beong-Ou Lim; Ji-Hong Lim
Journal:  Int J Mol Sci       Date:  2017-03-01       Impact factor: 5.923

6.  NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.

Authors:  Lindsay M Webb; Janiret Narvaez Miranda; Stephanie A Amici; Shouvonik Sengupta; Gregory Nagy; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 7.  Targeting MYC in cancer therapy: RNA processing offers new opportunities.

Authors:  Cheryl M Koh; Arianna Sabò; Ernesto Guccione
Journal:  Bioessays       Date:  2016-01-18       Impact factor: 4.345

8.  Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.

Authors:  Taek-In Oh; Yoon-Mi Lee; Taek-Jin Nam; Young-San Ko; Shinmee Mah; Jinhee Kim; Younghoon Kim; Rallabandi Harikrishna Reddy; Young Jun Kim; Sungwoo Hong; Ji-Hong Lim
Journal:  Int J Mol Sci       Date:  2017-09-29       Impact factor: 5.923

9.  Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening.

Authors:  Qianqian Wang; Jiahui Xu; Ying Li; Jumin Huang; Zebo Jiang; Yuwei Wang; Liang Liu; Elaine Lai Han Leung; Xiaojun Yao
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

10.  PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes.

Authors:  Jake L Owens; Elena Beketova; Sheng Liu; Samantha L Tinsley; Andrew M Asberry; Xuehong Deng; Jiaoti Huang; Chenglong Li; Jun Wan; Chang-Deng Hu
Journal:  iScience       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.